Although the conventional therapeutic approach is direct to provoke oxidative stress to promote cancer cell apoptosis [54,55], tumor cells respond to therapy by enhancing the antioxidant defense through HO-1 overexpression, therefore counteracting the efficacy of pharmacological treatment [25]. This evidence concerns the gene HMOX1 and cancer.